BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29749503)

  • 1. A gene interaction network‑based method to measure the common and heterogeneous mechanisms of gynecological cancer.
    Wang M; Li L; Liu J; Wang J
    Mol Med Rep; 2018 Jul; 18(1):230-242. PubMed ID: 29749503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNAs: Novel biomarkers for cervical, ovarian and endometrial cancer (Review).
    Shi Y; He R; Yang Y; He Y; Shao K; Zhan L; Wei B
    Oncol Rep; 2020 Nov; 44(5):1787-1798. PubMed ID: 33000238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Core Prognosis-Related Candidate Genes in Cervical Cancer via Integrated Bioinformatical Analysis.
    Wei J; Wang Y; Shi K; Wang Y
    Biomed Res Int; 2020; 2020():8959210. PubMed ID: 32258155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of gene expression in rats with spinal cord injury based on microarray data.
    Chen G; Fang X; Yu M
    Mol Med Rep; 2015 Aug; 12(2):2465-72. PubMed ID: 25936407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
    Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
    J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a potential prognostic lncRNA-miRNA-mRNA signature in endometrial cancer based on the competing endogenous RNA network.
    Wang Y; Huang T; Sun X; Wang Y
    J Cell Biochem; 2019 Nov; 120(11):18845-18853. PubMed ID: 31338870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bioinformatics analysis of the clinicopathological and prognostic significance of
    Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
    J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
    Xue B; Li S; Jin X; Liu L
    BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis.
    Zhong X; Huang G; Ma Q; Liao H; Liu C; Pu W; Xu L; Cai Y; Guo X
    Medicine (Baltimore); 2019 Jul; 98(27):e16269. PubMed ID: 31277149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of COL1A1 as an invasion‑related gene in malignant astrocytoma.
    Sun S; Wang Y; Wu Y; Gao Y; Li Q; Abdulrahman AA; Liu XF; Ji GQ; Gao J; Li L; Wan FP; Li YQ; Gao DS
    Int J Oncol; 2018 Dec; 53(6):2542-2554. PubMed ID: 30272346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential four‑miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co‑expression analysis.
    You L; Wang J; Zhang F; Zhang J; Tao H; Zheng X; Hu Y
    Mol Med Rep; 2019 Jan; 19(1):441-451. PubMed ID: 30483731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.
    Yang HJ; Xue JM; Li J; Wan LH; Zhu YX
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1200. PubMed ID: 32181600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of differentially expressed genes and biological pathways in bladder cancer.
    Tang F; He Z; Lei H; Chen Y; Lu Z; Zeng G; Wang H
    Mol Med Rep; 2018 May; 17(5):6425-6434. PubMed ID: 29532898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
    Liu H; Liu L; Zhu H
    J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.